Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award | MD | Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished radiologist and internationally respected leader in breast imaging, currently serving as Professor and Vice Chair for Breast Imaging in the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai, where she has made transformative contributions to breast cancer detection, digital imaging, and women’s health. Dr. Laurie Margolies completed her undergraduate studies in Biomedical Ethics at Brown University, earned her medical degree from Yale University School of Medicine, and pursued advanced clinical training through an internal medicine internship at Griffin Hospital, a radiology residency at Columbia-Presbyterian Medical Center, and a comprehensive fellowship in CT, ultrasound, and MRI at Yale University/Yale New Haven Hospital. Her professional experience spans decades of academic appointments, including Instructor at Yale, rising through faculty ranks at Mount Sinai from Assistant Professor to full Professor, while simultaneously serving as System Chief of Breast Imaging across multiple hospitals, Director of Breast Imaging at Mount Sinai Hospital, and Chief of Breast Imaging at the Dubin Breast Center. Dr. Laurie Margolies’s research interests center on breast cancer screening optimization, digital mammography, cardiovascular risk evaluation through mammographic arterial calcifications, health disparity reduction, culturally targeted education programs, imaging physics, AI-driven diagnostic tools, and cross-disciplinary cancer detection methods. Her research skills include expertise in multimodality breast imaging, tomosynthesis assessment, radiologic quality control, population-based screening program development, clinical guideline evaluation, and participation in collaborative research teams across oncology, epidemiology, psychology, and medical physics. She has contributed to impactful studies published in reputable journals such as the Journal of Breast Imaging, Clinical Imaging, Journal of Cancer Education, and PEC Innovation, and she has served on multiple advisory boards for leading medical technology companies, advancing AI-assisted imaging development. Dr. Laurie Margolies has received numerous honors, including Fellowship in the American College of Radiology, Fellowship in the Society of Breast Imaging, multiple RSNA Merit Awards, Mount Sinai Innovation Awards, Clinical Imaging Outstanding Reviewer recognition, and repeated selection as a Castle Connolly Top Doctor. She has served on key institutional committees, leadership panels, and mentoring programs, significantly shaping radiologic quality improvement and cancer screening strategies. Dr. Laurie Margolies continues to influence clinical practice through her dedication to research, patient-centered care, and educational advancement, embodying excellence in academic radiology and demonstrating ongoing potential to elevate global breast imaging standards.

Profile: ORCID | Google Scholar

Featured Publications 

  1. Margolies, L. R., Spear, G. G., Payne, J. I., Iles, S. E., & Abdolell, M. (2025). Artificial intelligence for assessment of digital mammography positioning reveals persistent challenges.

  2. Rossi, J., Cho, L., Newell, M. S., Venta, L. A., Montgomery, G. H., Destounis, S. V., Brem, R. F., Parghi, C., & Margolies, L. R. (2025). Breast arterial calcifications on mammography: A review of the literature.

  3. Mullen, L. A., Ambinder, E. B., Talati, N., & Margolies, L. R. (2023). Mammography information systems: A survey of breast imaging radiologist satisfaction and perspectives.

  4. Head, K. J., Harrington, N. G., Schnur, J. B., Margolies, L., & Montgomery, G. H. (2022). Examining gain- and loss-framed messages in a novel breast cancer screening/cardiovascular context: Does framing matter.

  5. Vang, S., Margolies, L. R., & Jandorf, L. (2022). Screening mammogram adherence in medically underserved women: Does language preference matter.

  6. Fung, J., Vang, S., Margolies, L. R., Li, A., Blondeau-Lecomte, E., Li, A., & Jandorf, L. (2021). Developing a culturally and linguistically targeted breast cancer educational program for a multicultural population.

  7. Margolies, L. R., Salvatore, M., Yip, R., Tam, K., Bertolini, A., Henschke, C., & Yankelevitz, D. (2018). The chest radiologist’s role in invasive breast cancer detection.

 

Nader Genedy | Medical Hypotheses | Best Researcher Award

Published on by Research Hypothesis

Dr. Nader Genedy | Medical Hypotheses | Best Researcher Award

Dr. Nader Genedy | Medical Hypotheses | Best Researcher Award | CRF Cardiology | University Hospital of Wales | United Kingdom 

Dr. Nader Genedy is an accomplished clinician–researcher whose work spans metabolic medicine, cardiology, geriatric care, and osteoporosis, integrating advanced academic training with extensive frontline clinical experience. Dr. Nader Genedy completed his medical degree at the University of Alexandria and progressed through multiple postgraduate qualifications, including MRCGP, MRCP(UK), MRCP(I), and specialist certification in acute internal medicine, enabling him to contribute meaningfully to both primary and specialist healthcare environments. Professionally, Dr. Nader Genedy serves as a GP with Special Interest in Osteoporosis and Geriatric Medicine, a Senior Research Fellow in Cardiology, and a Metabolic Medicine and Chemical Pathology Registrar, combining metabolic bone services, lipidology, endocrine disorders, and cardiovascular risk research with high standards of patient-centred care. His responsibilities extend to complex elderly care, DXA interpretation, risk-modelling analysis, and participation in multidisciplinary teams addressing metabolic and cardiovascular disorders. His research interests encompass atherosclerotic cardiovascular disease risk prediction, familial hypercholesterolaemia modelling, metabolic bone disease, cardiometabolic ageing, and biochemical diagnostics, with notable contributions to clinical trials such as RSA-PACE and metabolic therapeutics studies. Dr. Nader Genedy possesses advanced research skills, including statistical modelling, Cox regression, calibration analysis, SPSS/R processing, clinical dataset evaluation, and quality-improvement methodology, in addition to curriculum design, postgraduate teaching, and specialist question writing for MRCPUK examinations. His scholarly work includes conference presentations, co-authorship of national hyperlipidaemia management tools, and mentorship for postgraduate medical research candidates. Awards and honours recognising his excellence include the Bill Richmond First Prize from HEART UK, the Unsung Hero Award from the Inherited Metabolic Disease Service, multiple GREATix commendations for exemplary clinical service, and a patient feedback award for outstanding metabolic medicine contributions. Through his integrated roles in clinical care, research leadership, and academic assessment, Dr. Nader Genedy consistently demonstrates a strong commitment to advancing evidence-based practice, enhancing clinical education standards, and improving outcomes for complex elderly and cardiometabolic populations. In conclusion, Dr. Nader Genedy’s multifaceted expertise, dedication to research innovation, and ongoing contributions to both healthcare systems and academic scholarship establish him as a highly impactful medical professional whose work continues to influence patient care, clinical research, and postgraduate medical education.

Profile:  ORCID 

Featured Publications 

  1. Genedy, N., & Zouwail, S. (2025). ApoB/LDL-C discordance as a predictor of atherosclerotic cardiovascular disease in genetically confirmed heterozygous familial hypercholesterolemia: A hypothesis-generating cohort study. Journal of Clinical Lipidology.

  2. Genedy, N. (2024). Risk-modelling approaches for residual ASCVD in familial hypercholesterolaemia: An integrative clinical dataset analysis. Cardiometabolic Research Insights.

  3. Genedy, N. (2024). Metabolic bone disease assessment in primary care: Evaluating DXA utilisation and therapeutic optimisation. Journal of Osteoporosis and Geriatric Medicine.

  4. Genedy, N. (2023). Clinical implications of biochemical variability in lipidology clinics: A service-evaluation study. International Journal of Metabolic Medicine.

  5. Genedy, N. (2023). Post-CABG haemodynamic assessment: Inter-operator variability between USCOM and transthoracic echocardiography. Cardiovascular Clinical Methods Review.

  6. Genedy, N. (2022). Optimising hyperlipidaemia pathways: A quality-improvement initiative across multidisciplinary teams. British Journal of Clinical Pathway Innovation.

  7. Genedy, N. (2022). Clinical learning through biochemical case commentary: A structured model for postgraduate teaching. Medical Education Practice Journal.